News

2017.06.05News Release

Maruho and the Japanese Dermatological Association announce the Joint Operation of the Maruho Prize

2017.03.30News Release

Maruho receives manufacturing and marketing approval in Japan for Topical Scalp Psoriasis Treatment "Comclo^® Shampoo 0.05%"

2017.03.14News Release

Toray and Maruho Enter License Agreement for RORγt Inhibitor

2017.03.06News Release

Cutanea (Maruho's US Subsidiary) Unveils Aktipak™ (erythromycin and benzoyl peroxide) Gel, 3%/5%, Convenient Acne Treatment for "On-the-Go" Patients

2016.12.09News Release

The "Galderma Award" Transfers to Maruho

2016.11.04News Release

Maruho Launches Acne Vulgaris Treatment "Epiduo^® Gel" in Japan

2016.09.28News Release

Maruho and Astellas Enter License Agreement for the Development and Commercialization of a Topical Formulation of JAK Inhibitor peficitinib (ASP015K) for Treatment in the Skin Disease Area

2016.09.28News Release

Chugai and Maruho Announce License Agreement of Nemolizumab (CIM331), a Novel Biologic in the Skin Disease Area for the Japanese Market

2016.09.21News Release

Maruho enters a License Agreement with Dermira for Hyperhidrosis treatment agent DRM04

2016.09.16News Release

Maruho launches infantile hemangioma treatment"Hemangiol^® Syrup for Pediatric 0.375%" under a license from Pierre Fabre Laboratories

2016.07.20News Release

Maruho and Galderma Strengthen Strategic Alliance in Japan

2016.07.04News Release

Maruho receives manufacturing and marketing approval in Japan for infantile hemangioma treatment "Hemangiol^® Syrup for Pediatric 0.375%" under a license from Pierre Fabre Laboratories

2016.02.22News Release

Maruho Announces the Sixth Maruho Prize Winner, Award Ceremony and Lecture

2016.01.18News Release

Maruho and Galderma to Join Forces in a Strategic Alliance in Japan

2015.12.15News Release

Maruho to Dissolve UK Subsidiary

2015.10.01News Release

Maruho Merges its Consolidated US Subsidiaries